Home > PJ > Meetings and Conferences

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7170 p564-565
20 October 2001

This article
Reprint
Photocopy

Meetings and Conferences

National Association of Co-operative Executive Pharmacists summary


Managing current risks in community pharmacy

Current challenging areas in pharmacy are in local pharmaceutical services, the new contract, control of entry and intra-and extra-professional competition, said JOHN D’ARCY, chief executive, National Pharmaceutical Association.

LPS provides an alternative framework for contracting for pharmacy services but, at present, detail is lacking. They also provide the test-bed for the new contract. The Government is moving forward with LPS plans and has employed two people to work in the area. He said that the guidance on LPS has not been written yet so there is an opportunity for pharmacy to influence it.

Medicines management is a high priority area that covers a broad range of activities. It links with repeat dispensing, which Mr D’Arcy suggested should operate as a paper-based system in the short-term to lay the foundations for a future service. “If patients see pharmacy as the place where decisions on repeat dispensing occur, then this provides a platform for medicines management,” he said. An electronic link between general practitioners and pharmacists was needed or the provision of medicines management would be difficult.

The pharmacy plan gave an indication of the strategic intent on the future of community pharmacy, although it was lacking in indicators on delivery in terms of time and budget. However, a number of alarm bells were ringing. There are concerns over the new contract. Payment may no longer be based on volume of prescriptions and pharmacists have to recognise that simply doing what they had always done will no longer be enough, he said. In addition, pharmacists offering the best services will be paid more at the expense of those offering poorer services. Immediate issues for pharmacists include the loss of resale price maintenance (huge price cuts are expected in this winter’s cough and cold season), the inquiry into supply of generic medicines, the Office of Fair Trading’s control of entry inquiry and workforce issues. One thing that pharmacy has to do is protect the community pharmacy network, Mr D’Arcy said. If the Government started to dismantle the network it would be a risk for both pharmacy and consumers.

In terms of moving forward, community pharmacy has to assert itself, particularly in the core area of medicines skills. Pharmacy also has to be prepared to tackle no-go areas. “As a profession we are risk averse but in some areas we will need to take risks.” he said. Pharmacy should engage all stakeholders because it cannot operate in a vacuum. In addition, pharmacists need to co-operate with each other: “There are enough enemies outside the profession,” he said. This also applies to the professional bodies which must to collaborate to tackle the huge agenda facing pharmacy.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal